Calf blood deproteinized extract for injection

This product can enhance the uptake and utilization of oxygen and glucose by tissue cells and improve the cellular hypoxic state.

A sterile freeze-dried product containing inorganic and small molecular organic substances obtained by deproteinization, concentration, ultrafiltration or dialysis of fresh calf blood or serum

This product is white or slightly yellow freeze-dried product.

1. Various diseases that cause brain hypoxia, such as cerebral hemorrhage, cerebral embolism, encephalitis, cerebral arteriosclerosis, Alzheimer's disease, and resuscitation. 2. Acute and chronic hepatitis, symptomatic hepatitis, and liver cirrhosis. 3. Improve the quality of life of tumor patients and reduce the side effects of radiotherapy and chemotherapy. 4. Used as an energy mixture to treat myocarditis, coronary heart disease, etc. 5. Peptic ulcer, atrophic gastritis.

Intravenous drip. Stroke and brain trauma: 0.8-1.2g total solid amount (4-6 bottles) dissolved in 250ml 5% glucose injection or 0.9% sodium chloride injection, slowly dripped intravenously (drip rate less than 2ml/min) once a day, two weeks as a course of treatment.

Occasionally, there may be reactions such as fever, rash, and hypotension.

1. It is contraindicated for patients with severe renal dysfunction. 2. It is contraindicated for patients with allergic reactions to similar drugs.

Precautions for children: This product has not been tested and there is no reliable reference. Precautions for pregnancy and lactation: Use with caution. Precautions for the elderly: This product has not been tested and there is no reliable reference.

This product has not been tested and there is no reliable reference.

Protect from light and moisture

0.8g (total solid)

24 months

Jilin Connell Pharmaceutical Co., Ltd.

• Founded in:

  2001-11-28

• Address:

  No. 198, Chuangxin 3rd Road, High-tech Zone, Jilin City

• Tax NO.:

  91220214732553110Y

• Registered Funds:

  62.54717 million yuan

• Website:

  Log in to view

• Email:

  Log in to view